Clinical trial
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
NCT05017311 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 20, 2023
- Completion date
- April 30, 2029
- Enrollment
- 400 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.